Persistent alveolar inflammatory response in critically ill patients with COVID-19 is associated with mortality
IntroductionPatients with COVID-19-related acute respiratory distress syndrome (ARDS) show limited systemic hyperinflammation, but immunomodulatory treatments are effective. Little is known about the inflammatory response in the lungs and if this could be targeted using high-dose steroids (HDS). We...
Gespeichert in:
| Veröffentlicht in: | Thorax Jg. 78; H. 9; S. 912 - 921 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
England
BMJ Publishing Group Ltd and British Thoracic Society
01.09.2023
BMJ Publishing Group LTD |
| Schlagworte: | |
| ISSN: | 0040-6376, 1468-3296, 1468-3296 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!